Screening mammography in women aged 40-49 years

Medicine

Volumn 78, Issue 6, 1999, Pages 410-416

  Rajkumar, S Vincent ^a,b   Hartmann, Lynn C ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CARCINOMA; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; META ANALYSIS; PRIORITY JOURNAL; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS;

ADULT; AGE FACTORS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; RISK; RISK FACTORS;

EID: 0032719782     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-199911000-00006     Document Type: Article

References (33)

1. Andersson I, Janzon L. Reduced breast cancer mortality in women under age 50: Updated results from the Malmo mammographic screening program. Monogr Natl Cancer Inst 22: 63-67, 1997.
2. Bjurstam N, Bjorneld L, Duffy SW, Smith TC, Cahlin E, Erikson O, Hafstrom L, Lingaas H, Mattsson J, Persson S, Rudenstam C, Save-Soderberg J. The Gothenburg breast screening trial: First results on mortality, incidence and mode of detection for women ages 39-49 years at randomization. Cancer 80: 2091-99, 1997.
3. Boyd NF. The review of randomization in the Canadian National Breast Screening Study. Is the debate over? CMAJ 156: 207-9, 1997
4. Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare, Int J Cancer 68: 693-99, 1996.
5. Eastman P. NCI adopts new mammography screening guidelines for women. J Natl Cancer Inst 89: 538-39, 1997.
6. Elmore JG, Barton MB, Moceri VM, Polk S. Arena PJ, Fletcher SW. Tenyear risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 338: 1089-96, 1998.
7. Feig SA. Assessment of radiation risk from screening mammography. Cancer 77: 818-22, 1996.
8. Fletcher SW. Breast cancer screening among women in their forties: An overview of the issues. Monogr Natl Cancer Inst 22: 5-9, 1997.
9. Fletcher SW. Whither scientific deliberation in health policy recommendations? Alice in the Wonderland of breast-cancer screening. N Engl J Med 336: 1180-83, 1997.
10. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 85: 1644-56, 1993.
11. Frisell J, Lidbrink E. The Stockholm mammographic screening trial: Risks and benefits in age group 40-49 years. Monogr Natl Cancer Inst 22:49-51. 1997.
12. Glasziou P. Irwig L. The quality and interpretation of mammographic screening trials for women ages 40-49. Monogr Natl Cancer Inst 22: 73-77, 1997.
13. Hendrick RE. Smith RA. Rutledge JH III. Smart CR Benefit of screening mammography in women aged 40-19: A new meta-analysis of randomized clinical trials. Monogr Natl Cancer Inst 22: 87-92, 1997.
14. Hulka BS. Cancer screening. Degrees of proof and practical application. Cancer 62(Suppl): 1776-80, 1988.
15. Kerlikowske K. Efficacy of screening mammography among women aged 40-49 years and 50-69 years: Comparison of relative and absolute benefit. Monogr Natl Cancer Inst 22: 79-86, 1997.
16. Kerlikowske K, Barclay J. Outcomes of modern screening mammography. Monogr Natl Cancer Inst 22: 105-11, 1997.
17. Kerlikowske K, Grady D, Rubin SM, Sandrock C,. Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA 273: 149-54, 1995.
18. Khalkhali I, Cutrone JA, Mena IG, Diggles LE. Venegas RJ. Vargas HI, Jackson BL,. Khalkhali S, Moss JF, Klein SR. Scintimammography: The complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 196: 421-26, 1995.
19. Kopans DB. Updated results of the trials of screening mammography. Surg Oncol Clin North Am 6: 233-63, 1997.
20. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 49: 8-31, 1999.
21. Larsson L, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabar L, Nystrom L. Updated overview of the Swedish randomized trials on breast cancer screening with mammography: Age group 40-49 at randomization. Monogr Natl Cancer Inst 22: 57-61, 1997.
22. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 318: 1728-33, 1988.
23. Leitch AM, Dodd GD, Costanza M, Linver M, Pressman P, MrGinnis L., Smith RA. American Cancer Society guidelines for the early detection of breast cancer: Update 1997. CA Cancer J Clin 47: 150-53, 1997.
24. Mettler KA, Upton AC, Kelsey CA, Ashby RN, Rosenberg RD, Linver MN, Benefits versus risks from mammography: A critical reassessment. Cancer 77: 903-9, 1996.
25. Miller AB. The Canadian National Breast Screening Study: update on breast cancer mortality. Monogr Natl Cancer Inst 22: 37-11, 1997.
26. National Institutes of Health Consensus Development Conference Statement. Breast cancer screening for women ages 40-19. January 21-23, 1997. J Natl Cancer Inst 89: 1015-26, 1997.
27. Nystrom L. Rutqvist LE. Wall S. Lindgren A. Lindqvist M, Ryden S. Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabar L, Larsson L. Breast cancer screening with mammography: Overview of Swedish randomized trials. Lancet 341: 97:3-78. 1903.
28. Paykel J. Wolberg WH. Concerns about recommending routine screening mammograms for women aged 40-49 years [letter]. J Natl Cancer Inst 89: 889, 1997.
29. Rajkumar SV, Sampathkumar P. Gustafson AB. Number needed to treat is a simple measure of treatment efficacy for clinicians. J Genl Intern Med 11: 357-59, 1996.
30. Ransohoff DF, Harris RP. Lessons from the mammographic screening controversy: Can we improve the debate? Ann Intern Med 127: 1029-34, 1997.
31. Salzmann P, Kerlikowske K, Phillips K. Cost effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age. Ann Intern Med 127: 955-65, 1997.
32. Sox HC. Benefit and harm associated with screening for breast cancer. N Engl J Med 338: 1145-46, 1998.
33. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 30: 187-210, 1992.